Pfizer Inc. - PFE

PFE Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
PFE	-0.7	-2.1	-0.5	-10.1	-12.4	-6.6	-51.4	-31.5	-16.2	6023.0
S&P 500	1.0	1.8	-0.9	2.7	7.3	26.5	31.0	80.1	196.5	33856.2

Compare PFE with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	PFE
name	Pfizer Inc.
price	26.3
changes percentage	-0.7173
change	-0.19
day low	26.22
day high	26.56
year high	31.54
year low	24.48
market cap	149041837000
price avg 50	26.1762
price avg 200	27.8821
exchange	NYSE
volume	27472450
avg volume	43391963
open	26.395
previous close	26.49
eps	0.75
pe	35.07
earnings announcement	2025-02-04T13:30:00.000+0000
shares outstanding	5666990000
timestamp	2025-01-17 21:00:02

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 37.3%

Overall Quarterly Financial Health: 79.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000078003
revenue	58496000000	100330000000	-41.70
gross profit	28809000000	65986000000	-56.34
gross profit ratio	0.49	0.66	-25.12
research and development expenses	10679000000	11428000000	-6.55
operating expenses	25450000000	28714000000	-11.37
interest income	1624000000	251000000	547.01
interest expense	2209000000	1238000000	78.43
ebitda	9557000000	41031000000	-76.71
ebitdaratio	0.16	0.43	-62.44
operating income	3359000000	40030000000	-91.61
operating income ratio	0.06	0.4	-85.61
net income	2119000000	31372000000	-93.25
net income ratio	0.04	0.31	-88.42
eps	0.38	5.59	-93.20

Overall Score of Annual Income Statement

0.38 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 58,496 million in 2023 from 100,330 million in 2022 representing a change of -41.7%. This indicates a sales growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 25,450 million in 2023 from 28,714 million in 2022 representing a change of -11.37%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 9,557 million in 2023 from 41,031 million in 2022 representing a change of -76.71%. The increase in EBITDA indicates improved operational efficiency and profitability.

• 📉 Negative Indicators

  Gross Profit: Gross Profit decreased to 28,809 million in 2023 from 65,986 million in 2022 representing a change of -56.34%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 10,679 million in 2023 from 11,428 million in 2022 representing a change of -6.55%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Income: Operating income decreased to 3,359 million in 2023 from 40,030 million in 2022 representing a change of -91.61%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 2,119 million in 2023 from 31,372 million in 2022 representing a change of -93.25%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.38 in 2023 from 0.38 in 2022 representing a change of -93.2%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000078003
revenue	17702000000	13283000000	33.27
gross profit	11127000000	8243000000	34.99
gross profit ratio	0.63	0.62	1.29
research and development expenses	2598000000	2676000000	-2.91
operating expenses	5842000000	6364000000	-8.20
interest income	116000000	130000000	-10.77
interest expense	783000000	778000000	0.64
ebitda	7253000000	2405000000	201.58
ebitdaratio	0.41	0.27	50.76
operating income	5284000000	1879000000	181.21
operating income ratio	0.3	0.14	111.01
net income	4465000000	24000000	18504.17
net income ratio	0.25	0.0	13859.96
eps	0.79	0.0	18709.52

Overall Score of Quarterly Income Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 17,702 million in 2024Q3 from 13,283 million in 2024Q2 representing a change of 33.27%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 11,127 million in 2024Q3 from 8,243 million in 2024Q2 representing a change of 34.99%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 5,842 million in 2024Q3 from 6,364 million in 2024Q2 representing a change of -8.2%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 7,253 million in 2024Q3 from 2,405 million in 2024Q2 representing a change of 201.58%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 5,284 million in 2024Q3 from 1,879 million in 2024Q2 representing a change of 181.21%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 4,465 million in 2024Q3 from 24 million in 2024Q2 representing a change of 18504.17%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.79 in 2024Q3 from 0.79 in 2024Q2 representing a change of 18709.52%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 2,598 million in 2024Q3 from 2,676 million in 2024Q2 representing a change of -2.91%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000078003
total assets	226501000000	197206000000	14.86
total liabilities	137213000000	101289000000	35.47
total equity	89288000000	95917000000	-6.91
cash and cash equivalents	2853000000	416000000	585.82
short term investments	9837000000	22316000000	-55.92
long term investments	15770000000	15069000000	4.65
total current assets	43333000000	51259000000	-15.46
total non current assets	183168000000	145944000000	25.51
total current liabilities	47794000000	42138000000	13.42
total non current liabilities	89419000000	59151000000	51.17
common stock	478000000	476000000	0.42
retained earnings	118353000000	125656000000	-5.81
total debt	70845000000	34870000000	103.17

Overall Score of Annual Balance Sheet

0.3 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 226,501 million in 2023 from 197,206 million in 2022 representing a change of 14.86%. Suggesting a growth in asset holdings.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 2,853 million in 2023 from 416 million in 2022 representing a change of 585.82%. This indicates an increase in available liquid assets.

  Common Stock: Common Stock increased to 478 in 2023 from 476 in 2022 representing a change of 0.42%. This indicates an increase in ownership interest.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 137,213 million in 2023 from 101,289 million in 2022 representing a change of 35.47%. This indicates an increase in overall liabilities.

  Total Equity: Total Equity decreased to 89,288 million in 2023 from 95,917 million in 2022 representing a change of -6.91%. This indicates a decrease in shareholders' equity.

  Short Term Investments: Short Term Investments decreased to 9,837 million in 2023 from 22,316 million in 2022 representing a change of -55.92%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 43,333 million in 2023 from 51,259 million in 2022 representing a change of -15.46%. This indicates a worsen liquidity position.

  Total Current Liabilities: Total Current Liabilities increased to 47,794 million in 2023 from 42,138 million in 2022 representing a change of 13.42%. This indicates a higher short-term debt burden.

  Retained Earnings: Retained Earnings decreased to 118,353 million in 2023 from 125,656 million in 2022 representing a change of -5.81%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 70,845 million in 2023 from 34,870 million in 2022 representing a change of 103.17%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000078003
total assets	219476000000	216193000000	1.52
total liabilities	126918000000	128219000000	-1.01
total equity	92558000000	87975000000	5.21
cash and cash equivalents	1092000000	1052000000	3.80
short term investments	8860000000	6048000000	46.49
long term investments	10762000000	11522000000	-6.60
total current assets	43223000000	37825000000	14.27
total non current assets	176253000000	178368000000	-1.19
total current liabilities	43211000000	43819000000	-1.39
total non current liabilities	83707000000	84400000000	-0.82
common stock	480000000	480000000	0.00
retained earnings	121059000000	116596000000	3.83
total debt	66617000000	69450000000	-4.08

Overall Score of Quarterly Balance Sheet

1.0 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 219,476 million in 2024Q3 from 216,193 million in 2024Q2 representing a change of 1.52%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 126,918 million in 2024Q3 from 128,219 million in 2024Q2 representing a change of -1.01%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 92,558 million in 2024Q3 from 87,975 million in 2024Q2 representing a change of 5.21%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 1,092 million in 2024Q3 from 1,052 million in 2024Q2 representing a change of 3.8%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 8,860 million in 2024Q3 from 6,048 million in 2024Q2 representing a change of 46.49%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 43,223 million in 2024Q3 from 37,825 million in 2024Q2 representing a change of 14.27%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 43,211 million in 2024Q3 from 43,819 million in 2024Q2 representing a change of -1.39%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 121,059 million in 2024Q3 from 116,596 million in 2024Q2 representing a change of 3.83%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 66,617 million in 2024Q3 from 69,450 million in 2024Q2 representing a change of -4.08%. This indicates a reduction in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000078003
net change in cash	2449000000	-1515000000	261.65
operating cash flow	8700000000	29267000000	-70.27
free cash flow	4793000000	26031000000	-81.59
capital expenditure	-3907000000	-3236000000	-20.74
depreciation and amortization	6290000000	5064000000	24.21
deferred income tax	-3442000000	-3764000000	8.55
stock based compensation	525000000	872000000	-39.79
accounts payables	-300000000	1191000000	-125.19
inventory	6199000000	592000000	947.13
acquisitions net	-43430000000	-22997000000	-88.85
investments in property plant and equipment	-3907000000	-3236000000	-20.74
net cash used for investing activites	-32278000000	-15783000000	-104.51
debt repayment	35945000000	-3516000000	1122.33
common stock issued	0	0	NaN
common stock repurchased	0	-2000000000	100.00
dividends paid	-9247000000	-8983000000	-2.94
net cash used provided by financing activities	26066000000	-14834000000	275.72
cash at end of period	2917000000	468000000	523.29
accounts receivables	347000000	261000000	32.95
cash at beginning of period	468000000	1983000000	-76.40

Overall Score of Annual Cashflow Statement

0.44 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 2,449 million in 2023 from -1,515 million in 2022 representing a change of 261.65%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure decreased to -3,907 million in 2023 from -3,236 million in 2022 representing a change of -20.74%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Stock-Based Compensation: Stock-Based Compensation decreased to 525 million in 2023 from 872 million in 2022 representing a change of -39.79%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 300 million in 2023 from 1,191 million in 2022 representing a change of -125.19%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 8,700 million in 2023 from 29,267 million in 2022 representing a change of -70.27%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 4,793 million in 2023 from 26,031 million in 2022 representing a change of -81.59%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Deferred Income Tax: Deferred Income Tax increased to -3,442 million in 2023 from -3,764 million in 2022 representing a change of 8.55%. This indicates that the company's tax liability for future periods has increased.

  Accounts Receivables: Accounts Receivables increased to 347 in 2023 from 261 million in 2022 representing a change of 32.95%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -9,247 million in 2023 from -8,983 million in 2022 representing a change of -2.94%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000078003
operating cash flow	6714000000	-1782000000	476.77
free cash flow	6063000000	-2419000000	350.64
capital expenditure	-651000000	-637000000	-2.20
depreciation and amortization	1755000000	1731000000	1.39
deferred income tax	-482000000	-783000000	38.44
stock based compensation	274000000	206000000	33.01
accounts receivables	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	-651000000	-637000000	-2.20
net cash used for investing activites	-2057000000	4600000000	-144.72
debt repayment	-2250000000	-16000000	-13962.50
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-2380000000	-2380000000	0.00
net cash used provided by financing activities	-4636000000	-2459000000	-88.53
net change in cash	100000000	333000000	-69.97
cash at end of period	1152000000	1052000000	9.51
cash at beginning of period	1052000000	719000000	46.31

Overall Score of Quarterly Cashflow Statement

0.5 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to 100 million in 2024Q3 from 333 million in 2024Q2 representing a change of -69.97%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Deferred Income Tax: Deferred Income Tax increased to -482 million in 2024Q3 from -783 million in 2024Q2 representing a change of 38.44%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 274 million in 2024Q3 from 206 million in 2024Q2 representing a change of 33.01%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 6,714 million in 2024Q3 from -1,782 million in 2024Q2 representing a change of 476.77%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 6,063 million in 2024Q3 from -2,419 million in 2024Q2 representing a change of 350.64%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -651 million in 2024Q3 from -637 million in 2024Q2 representing a change of -2.2%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q1 2025 Earnings call transcript
Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	10.37	17.89	-42.06
net income per share	0.38	5.59	-93.29
operating cash flow per share	1.54	5.22	-70.46
free cash flow per share	0.85	4.64	-81.70
cash per share	2.25	4.05	-44.52
book value per share	15.82	17.1	-7.49
tangible book value per share	-7.69	0.21	-3779.68
shareholders equity per share	15.77	17.06	-7.53
interest debt per share	12.95	6.44	101.07
market cap	162461970000	287353920000	-43.46
enterprise value	230453970000	321807920000	-28.39
pe ratio	76.67	9.16	737.04
price to sales ratio	2.78	2.86	-3.03
pocfratio	18.67	9.82	90.19
pfcf ratio	33.9	11.04	207.06
pb ratio	1.83	3.0	-39.24
ptb ratio	1.83	3.0	-39.24
ev to sales	3.94	3.21	22.83
enterprise value over ebitda	24.11	7.84	207.45
ev to operating cash flow	26.49	11.0	140.91
ev to free cash flow	48.08	12.36	288.93
earnings yield	0.01	0.11	-88.05
free cash flow yield	0.03	0.09	-67.43
debt to equity	0.8	0.36	118.34
debt to assets	0.31	0.18	76.89
net debt to ebitda	7.11	0.84	747.24
current ratio	0.91	1.22	-25.47
interest coverage	1.52	32.33	-95.30
income quality	4.01	0.93	329.76
dividend yield	0.06	0.03	82.07
payout ratio	4.36	0.29	1424.02
sales general and administrative to revenue	0.19	0.11	74.58
research and ddevelopement to revenue	0.18	0.11	60.27
intangibles to total assets	0.59	0.48	21.93
capex to operating cash flow	0.45	0.11	306.16
capex to revenue	0.07	0.03	107.08
capex to depreciation	0.62	0.64	-2.80
stock based compensation to revenue	0.01	0.01	3.26
graham number	11.54	46.34	-75.09
roic	0.04	0.23	-84.42
return on tangible assets	0.02	0.31	-92.62
graham net net	-19.68	-11.74	-67.58
working capital	-4461000000	9121000000	-148.91
tangible asset value	-43395000000	1172000000	-3802.65
net current asset value	-93880000000	-50030000000	-87.65
invested capital	150086000000	120140000000	24.93
average receivables	11064500000	11215500000	-1.35
average payables	6759500000	6193500000	9.14
average inventory	9585000000	9020000000	6.26
days sales outstanding	69.74	39.84	75.04
days payables outstanding	82.5	72.36	14.00
days of inventory on hand	125.27	95.45	31.25
receivables turnover	5.23	9.16	-42.87
payables turnover	4.42	5.04	-12.28
inventory turnover	2.91	3.82	-23.81
roe	0.02	0.33	-92.74
capex per share	0.69	0.58	19.99

• Negative

  ROE: Return on Equity (ROE) decreased to 0.02 on 2023-12-31 from 0.33 on 2022-12-31, representing a change of -92.74%. Suggesting that the company has not been generating high returns for its shareholders.

  Current Ratio: Current Ratio decreased to 0.91 on 2023-12-31 from 1.22 on 2022-12-31, representing a change of -25.47%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Also, it's below 1, indicating potential liquidity issues.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 76.67 on 2023-12-31 from 9.16 on 2022-12-31, representing a change of 737.04%. Indicating an increase in the relative valuation of the company's stock.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.80 on 2023-12-31 from 0.36 on 2022-12-31, representing a change of 118.34%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-09-29 Q3	2024-06-30 Q2	Q/Q change %
PFE
calendar year	2024	2024	NaN
revenue per share	3.12	2.34	33.24
net income per share	0.79	0.0	18500.88
operating cash flow per share	1.18	-0.31	476.70
free cash flow per share	1.07	-0.43	350.60
cash per share	1.76	1.25	40.14
book value per share	16.33	15.53	5.19
tangible book value per share	-6.35	-7.36	13.71
shareholders equity per share	16.28	15.48	5.21
interest debt per share	11.89	12.39	-4.04
market cap	164002980000	159894520000	2.57
enterprise value	229527980000	228292520000	0.54
pe ratio	9.18	1665.57	-99.45
price to sales ratio	9.26	12.04	-23.04
pocfratio	24.43	-89.73	127.22
pfcf ratio	27.05	-66.1	140.92
pb ratio	1.78	1.82	-2.53
ptb ratio	1.78	1.82	-2.53
ev to sales	12.97	17.19	-24.56
enterprise value over ebitda	31.65	94.92	-66.66
ev to operating cash flow	34.19	-128.11	126.69
ev to free cash flow	37.86	-94.37	140.11
earnings yield	0.03	0.0	18038.11
free cash flow yield	0.04	-0.02	344.36
debt to equity	0.72	0.79	-8.85
debt to assets	0.3	0.32	-5.51
net debt to ebitda	9.03	28.44	-68.23
current ratio	1.0	0.86	15.88
interest coverage	6.75	2.42	179.42
income quality	1.5	-74.25	102.02
dividend yield	0.01	0.01	-2.51
payout ratio	0.53	99.17	-99.46
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.15	0.2	-27.15
intangibles to total assets	0.59	0.6	-2.35
capex to operating cash flow	0.1	-0.36	127.12
capex to revenue	0.04	0.05	-23.31
capex to depreciation	0.37	0.37	0.80
stock based compensation to revenue	0.02	0.02	-0.19
graham number	16.99	1.21	1298.93
roic	0.03	-0.0	967.87
return on tangible assets	0.05	0.0	17601.38
graham net net	-17.69	-18.86	6.18
working capital	12000000	-5994000000	100.20
tangible asset value	-35998000000	-41711000000	13.70
net current asset value	-83695000000	-90394000000	7.41
invested capital	147109000000	142648000000	3.13
average receivables	12922000000	11191000000	15.47
average payables	5210000000	5348500000	-2.59
average inventory	11584500000	11170000000	3.71
days sales outstanding	73.47	77.19	-4.82
days payables outstanding	72.74	91.18	-20.22
days of inventory on hand	160.44	204.43	-21.52
receivables turnover	1.22	1.17	5.07
payables turnover	1.24	0.99	25.35
inventory turnover	0.56	0.44	27.42
roe	0.05	0.0	17579.66
capex per share	0.11	0.11	2.18

• Negative

  ROE: Return on Equity (ROE) increased to 0.05 on 2024-09-29 Q3 from 0.00 on 2024-06-30 Q2, representing a change of 17579.66%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 9.18 on 2024-09-29 Q3 from 1665.57 on 2024-06-30 Q2, representing a change of -99.45%. Indicating a decrease in the relative valuation of the company's stock.

• Positive

  Current Ratio: Current Ratio increased to 1.00 on 2024-09-29 Q3 from 0.86 on 2024-06-30 Q2, representing a change of 15.88%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.72 on 2024-09-29 Q3 from 0.79 on 2024-06-30 Q2, representing a change of -8.85%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 63.4 which is higher than current price 26.3, indicates the company may be undervalued.